Jun 2011

Home >> Clinical Trials News Archive >> 2011 >> Jun 2011
Israeli economy grows 4.7% in Q1. Rise in GDP lower than 7.6% growth in last quarter of 2010, but matches Bank of Israel's forecast.
 
Israel 17th most competitive economy. IMD World Competitiveness Yearbook ranks Jewish state first in R&D investments, central bank's positive impact
 
Israel’s Teva acquires Taiyo, becomes leader in Japanese generics. Taiyo has one of the most comprehensive generic product portfolios in the Japanese market and has a strong presence in all major distribution channels in Japan.
 
EU finalizes guidance on reporting adverse events from clinical trials. The European Commission has published the final version of its guidance on the collection, verification and presentation of adverse events reports from human drug trials. The guidance is designed to provide stakeholders with a "short-term" fix for certain problems relating to the clinical trials.
 
 
Akron venture firm aims for Israeli medical device imports. Through an innovative partnership with an Israeli technology incubator, Akron venture capital firm Everett Partners is hoping to bring several medical device firms’ U.S. headquarters to Northeast Ohio.